Financial Data and Key Metrics Changes - The company recorded normalized EBITDA of $11.2 million, a $13 million improvement compared to the previous corresponding period (PCP) [10] - Group revenue increased by 6% to $261.4 million, with gross profit rising to $137 million, up from $126 million, resulting in a gross profit margin of 52.4% [18][19] - The gross profit margin decreased by 0.4 percentage points compared to the PCP [19] Business Line Data and Key Metrics Changes - In Australia, revenue reached a record $218.5 million, up 3% from the PCP, with gross profit also at a record $114.5 million, up 2% [11] - The Australian gross win margin improved by 1.8 percentage points to 13.6%, while the net win margin increased by 1 percentage point to 10.4% [12] - In Canada, net win grew by 26% to $43 million, with sports betting net win at $17 million, up 11%, and iGaming net win at $26 million, up 39% [15][16] Market Data and Key Metrics Changes - The Australian wagering market experienced a material decline, estimated at around 7% for the year, despite PointsBet gaining market share [26] - The Canadian market showed strong turnover growth, maintaining PointsBet's net win market share [15] Company Strategy and Development Direction - PointsBet aims to diversify its revenue base by focusing on mass market recreational segments in both Australia and Canada [10] - The company is actively encouraging reforms in the wagering industry regarding advertising to leverage digital and social media platforms [14] Management Comments on Operating Environment and Future Outlook - Management noted that the Australian market has not grown at a net win level, but there are signs of improvement in the last quarter [26] - The company expects continued market growth tailwinds in the regulated Canadian market [17] Other Important Information - PointsBet paid $115.3 million in taxes and fees to Australian governments and racing bodies, representing 47.9% of its net win for the year [14] - The company had $22.7 million in corporate cash and net assets of $6 million as of June 30, 2025 [21] Q&A Session Summary Question: What is the estimated decline in the Australian wagering market for FY 2025? - Management agreed with estimates of around 7% decline, noting that the last quarter showed some positive margins for operators [26] Question: What are the next steps if MiXi increases above 50.1%? - If MiXi goes through 50.1% before the offer closes, it would trigger a two-week extension for the offer [28][29]

For personal use only FY25 : RESULTS PRESENTATION | August 29 2025 N B C U N I V E R S A L M E D I A P A R T N E R S H I P & F Y 2 0 R E S U L T S P R E S E N T A T I O N │ A U G U S T 2 0 2 0 FY25 RESULTS PRESENTATION AUG 2025 IMPORTANT NOTICE AND DISCLAIMER This document and any oral presentation accompanying it has been prepared in good faith, however, no express or implied representation or warranty is given as to the accuracy or completeness of the information in this document, in any accompanying pres ...

Core Viewpoint - Innosera ApS, controlled by Nordic Capital Fund XI and Permira, has made a voluntary all-cash takeover offer for Bavarian Nordic A/S at DKK 233.0 per share, with a revised minimum acceptance condition of 75% of shares [1][3]. Group 1: Offer Details - The takeover offer is for all issued and outstanding shares of Bavarian Nordic, excluding treasury shares [1]. - The offer document has been approved by the Danish Financial Supervisory Authority and includes an acceptance form [1]. - The initial minimum acceptance condition was over 90% but has been lowered to 75% [3]. Group 2: Shareholder Guidance - Shareholders are advised to read the Offer Document and the forthcoming Board Statement in full before making a decision [4]. - The Board of Directors will issue a statement regarding the Offer as soon as possible [2]. Group 3: Company Background - Bavarian Nordic is a global vaccine company focused on innovative vaccines, including mpox and smallpox vaccines, and has a strong portfolio of travel vaccines [7].

Core Viewpoint - Bavarian Nordic A/S has entered into an agreement with Innosera ApS for a recommended voluntary public takeover offer at DKK 233 per share, valuing the company at approximately DKK 19 billion [1][2]. Offer Highlights - The offer price of DKK 233 represents a 21.0% premium over the closing price of DKK 192.50 on July 23, 2025 [2]. - The offer price reflects a 31.0% premium compared to the one-month volume-weighted average share price of DKK 177.92, a 35.5% premium over the three-month average of DKK 171.99, and a 37.4% premium over the six-month average of DKK 169.60 [2]. - The Board of Directors of Bavarian Nordic intends to recommend that shareholders accept the offer [2][7]. Board of Directors' Position - The Board believes the offer is attractive and has unanimously decided to recommend acceptance to shareholders [2][7]. - All members of the Board and Executive Management have committed to tender their shares, representing 0.30% of the voting rights and share capital [2]. Offer Process and Conditions - The Offeror will publish an offer document approved by the Danish Financial Supervisory Authority within four weeks [2][14]. - The offer period is expected to last six weeks, subject to extension [2][16]. - Completion of the offer is contingent upon obtaining over 90% of voting rights, necessary regulatory approvals, and no adverse changes occurring [2][12]. Strategic Rationale - Nordic Capital and Permira believe the acquisition will accelerate Bavarian Nordic's growth strategy and enhance its position in the global vaccine market [4][5]. - The transformation of Bavarian Nordic into a leading international vaccine company is ongoing and will require continued investment [4]. Commitment to Stakeholders - Nordic Capital and Permira intend to support Bavarian Nordic's mission to provide life-saving vaccines and maintain operations in partnership with management and employees [6]. - The Offeror aims to create long-term value for all stakeholders, including society and patients [6]. Financial Advisors - Citigroup Global Markets Europe AG and Nordea Danmark are acting as financial advisors to Bavarian Nordic [18].

Core Viewpoint - Bastion Mining Pte Ltd has made an off-market takeover offer to acquire all fully paid ordinary shares of Xanadu Mines Ltd at a price of A$0.08 per share, representing a significant premium to the current market price [1][7][9]. Offer Details - The offer price of A$0.08 per share represents a 57% premium to Xanadu's closing price of A$0.051 on May 16, 2025 [7][13]. - The total equity value implied by the offer for Xanadu is A$160 million, excluding a proposed share issue to Bastion [7]. - Bastion plans to subscribe for 286,829,633 shares in Xanadu at A$0.06 per share, amounting to an initial investment of A$17.2 million [7][22]. Recommendations and Support - Xanadu's Takeover Board Committee unanimously recommends that shareholders accept the offer, pending the conclusion of an Independent Expert that the offer is fair and reasonable [4][8][10]. - CAAF Ltd, Xanadu's largest independent shareholder, holding 11.85% of shares, has also confirmed its intention to accept the offer [9][12]. Conditions and Commitments - The offer is contingent upon Bastion acquiring at least 50.1% of Xanadu shares, after which it will declare the offer unconditional [7][11][15]. - The Bid Implementation Agreement includes standard terms such as exclusivity arrangements and a right for Bastion to match any competing proposal [15][16]. Timeline and Next Steps - The indicative timetable for the offer includes key dates such as the opening of the offer period on May 28, 2025, and the closing of the offer period unless extended [25][23]. - Xanadu will host a conference call on May 21, 2025, to discuss the offer further [12]. Company Background - Xanadu Mines is an exploration company listed on ASX and TSX, focusing on significant copper-gold discoveries in Mongolia, particularly the Kharmagtai project [28].